<DOC>
	<DOCNO>NCT00074776</DOCNO>
	<brief_summary>This study compare medication lithium lamotrigine ( LamictalÂ® ) treat depression individual bipolar II disorder .</brief_summary>
	<brief_title>Acute Treatment Bipolar II Depression</brief_title>
	<detailed_description>Bipolar II disorder ( BDII ) serious condition characterize depressive hypomanic episode . The disability suicide risk associate BDII equal bipolar I disorder . However , clinical trial BDII , treatment BDII address current treatment guideline . Data suggest Li LTG may effective treatment option BDII . This study determine safety , effectiveness , tolerability two drug people BDII . Participants study randomly assign receive either Li LTG 16 week . Participants assess every 2 week . One week study completion , participant follow-up visit . Measures depression , mania , quality life , functioning , participant satisfaction take .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Current diagnosis bipolar II disorder Use lithium lamotrigine Intolerance lithium lamotrigine Substance abuse dependence within last month Suicidal thought Unstable medical condition Pregnancy breastfeed Stable current medication Use fluoxetine ( Prozac ) within 2 week study Require antipsychotic medication Do speak read English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Bipolar Depression</keyword>
</DOC>